Description
Bufocort 200 mg is a dry powder inhalation capsule manufactured by Square Pharmaceuticals Ltd., commonly used for the treatment and maintenance of asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents aged 12 years and older. The combination of Budesonide, a corticosteroid, and Formoterol Fumarate, a long-acting beta-agonist, works synergistically to reduce inflammation and relax bronchial muscles, thereby improving airflow and reducing symptoms such as wheezing and shortness of breath
.jpeg)
.png)
.jpeg)
.webp)
.webp)
.webp)
.jpeg)
.png)
.png)
Change Language